The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.
On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.
Medicare may be shelling out an extra $1.2 billion in overpayments for graduate medical education (GME), which trains medical residents, according to a study published in JAMA Internal Medicine.
Sensyne Health announced Thursday, Oct. 10, that it has joined Bayer’s newest innovation hub, LifeHub UK, and will work toward developing solutions for automated image evaluation.
A team of researchers from West Virginia and Arkansas are beginning a four-year project aimed at using AI to improve the treatment of cardiovascular disease and cut healthcare costs.
Johnson & Johnson was hit with an $8 billion judgment and ordered to pay a Maryland man after the company failed to sufficiently warn users that its antipsychotic drug Risperdal could cause breast growth in men.
As more businesses begin to implement state-of-the-art technologies, one industry expert is predicting AI will boost the global economy by $14 trillion by the year 2035.
